In a single blind randomised control pilot study, curcuminoids or placebo was administered orally, 2 grams twice daily to a cohort of 26 MGUS patients. |
Curcuminoids were administered at a daily dose of 1 g, and were co-supplemented with piperine in order to boost oral bioavailability. |